Digital Pathology Market - Global Industry Analysis, Size, Growth Trends, Share, Opportunities and Forecast 2012 â€“ 2020 Get the full access of the report of http://www.alliedmarketresearch.com/digitalpathology-market=74
The adoption and progress of technology is on a tremendous rise in the biological industry. Research and advancements are going on to replace conventional practices with advanced technologies. The inclination of consumers and government towards patient safety and accurate diagnosis is a growing trend, which emphasizes the need for advanced pathological analysis. Pathology is a crucial aspect of patient care, and digital pathology has the potential to serve the underlying purpose, which encourages digitization of pathology and laboratory data for improved efficacy and productivity. Invitro diagnostics market reached about 53 billion in 2012 growing at a CAGR of 7.3%. The digital pathology is presently garnering a lot of attention owing to its ability to improve workflow efficiency of pathologists and reduce costs involved in the process of pathology. It offers accessibility to quality slide images that help in accurate and fast diagnosis, and allows preservation of such slides for further use. Improved patient care, reduction in laboratory expenses, and improvement in operational efficiency are the driving factors of this market. Besides this, increasing incidences of cancer and other chronic diseases, mounting trends in drug development, and companion diagnostics are the key drivers, which are likely to enhance the growth of this market in the near future. However, strict regulations, high cost, and technological issues may restrict the market growth. Although these issues are prevalent in the market, benefits of digital pathology to the fields of diagnostic care, clinical research, education, and biopharma applications are pushing new companies to focus on the existing and future growth opportunities, and work towards the development of this market. The digital pathology market is categorized into markets by application, products, and geography segments. The digital pathology application market segment consists of human pathology and animal pathology. On the basis of products, it is segmented into scanners, analytics, communication and storage. This market is also segmented by end users such as pharmaceutical and biotechnology companies, diagnostic laboratories, hospitals and other medical centres, academic institution, contract research organization (CROs), research and others. The digital pathology market by geography is segmented into North America, Asia Pacific, Europe, Latin America and RoW. Currently, North America occupies a major portion of the digital pathology market, followed by Europe, which is an outcome of wide adoption of digital pathology systems by pharmaceutical companies and clinical research labs. Even, the markets in emerging economies are forecasted to experience moderate growth, with more awareness
about the technology and its cost-effectiveness. Leading players in the market are Omnyx LLC, Aperio Technologies Inc., Philips Healthcare, Ventana Medical Systems Inc., Claro Inc., DMetrix Inc., Digipath Inc., 3DHistech Ltd., Mikroscan Technologies Inc., and Nikon Instruments Inc. Strategies such as product launches, collaborations, and mergers and acquisitions are being adopted for the growth of this market. For instance, Ventana and EMC have recently signed a collaboration agreement, intended at providing a flexible and highly scalable solution to store and archive medical images for anatomical pathology labs. Market attractiveness analysis, compares various types of products and end users within their respective markets along with factors responsible for the most attractive market. Market attractiveness analysis for the most attractive geographical region worldwide is also considered and has detailed study of factors responsible for rapid growth in the regions. Various economic factors which are significant in determining market trend, buying decisions and market attractiveness had been analyzed for market estimation and forecasting. Detailed elaboration of drivers, restraints and opportunities in the report will enable in strategic decision making with perceptive to identify potential market. In addition to this, the study also discusses various environmental and regulatory factors critical for the market growth. Thus, estimation of market numbers, with due consideration to all these factors has helped in enhancing the scope of the report. This analysis will support stakeholders such as manufacturers and distributers in identifying and capturing markets with high potential. Historical data is provided for 2011, 2012 whereas forecast is available through 2020 in terms of revenue (million) for each and every segments. The digital pathology market segmentations are as follows: Application Human Pathology • Animal Pathology •
Products Scanners Analytics Communication Storage
End Users 1. Pharmaceutical and biotechnology companies 2. Diagnostic laboratories, hospitals and other medical centres 3. Academic institution 4. Contract research organization (CROs) 5. Research 6. Others
Asia Pacific • Europe • Row 1. Introduction 1.1. Scope and Coverage 1.2. Report Description 1.3. Key Stakeholders 1.4. Research Methodology 2. Executive Summary 3. Global Mobile Healthcare (mHealth) Market Overview 3.1. Introduction 3.2. Market Dynamics 3.2.1. Drivers 220.127.116.11. Integration of Wireless Technologies with Portable Healthcare Devices 18.104.22.168. Increasing Lifestyle Disease 22.214.171.124. Cost and Convenience Factors 126.96.36.199. Technological Innovations 188.8.131.52. Government Initiatives 184.108.40.206. Affordability of Smartphones 3.2.2. Restraints 220.127.116.11. Lower Adoption due to Lack of Accuracy and Technology Infancy 18.104.22.168. Weak Reimbursement Coverage 22.214.171.124. Technological Awareness Among the Ageing Population 126.96.36.199. Uncertainty in the Government Regulations is Responsible for Mundane Growth Rate 3.2.3. Opportunities 188.8.131.52. Untapped Market of Developing Economies 184.108.40.206. Rising Opportunities for Mobile Medical Devices Manufacturers in the form of Bundled Services 4. Global Mobile Healthcare (mHealth) Market - by Devices 4.1. Blood Glucose Meters 4.1.1. Market Size and Forecast, by Geography, 2012 – 2020 ($Million) 4.1.2. Market Trends 4.1.3. Key Market Drivers 220.127.116.11. Rise in Incidences of Diabetes 18.104.22.168. Round-the-Clock Monitoring 4.1.4. Market Restraints 22.214.171.124. Accuracy an Issue 126.96.36.199. Complexity 4.1.5. Market Opportunities 4.2. BP Monitors 4.2.1. Market Size and Forecast, by Geography, 2012 – 2020 ($Million) 4.2.2. Market Trends 4.2.3. Key Market Drivers 188.8.131.52. Rise in Incidences of Hypertension 184.108.40.206. Need to Continuously Monitor BP •
4.2.4. Market Restraints 220.127.116.11. Accuracy as a Concern 4.2.5. Market Opportunities 4.3. Pulse Oximeters 4.3.1. Market Size and Forecast, by Geography, 2012 – 2020 ($Million) 4.3.2. Market Trends 4.3.3. Key Market Drivers 4.3.4. Market Restraints 4.3.5. Market Opportunity 4.4. Neurological Monitoring 4.4.1. Market Size and Forecast, by Geography, 2012 – 2020 ($Million) 4.4.2. Market Trends 4.4.3. Key Market Drivers 18.104.22.168. Increase in Incidences of Neurological Disorders 22.214.171.124. Technological Advancement 4.4.4. Market Restraints 126.96.36.199. High Price 4.4.5. Market Opportunity 4.5. Cardiac Monitors 4.5.1. Market Size and Forecast, by Geography, 2012 – 2020 ($Million) 4.5.2. Market Trends 4.5.3. Key Market Drivers 188.8.131.52. Rising Incidences of Heart Diseases 4.5.4. Market Restraint 184.108.40.206. Standardization and Inter-Operability a Concern 4.5.5. Market Opportunity 220.127.116.11. Lack of Trained Healthcare Professionals 4.6. Apnea & Sleep Monitor 4.6.1. Market Size and Forecast, by Geography, 2012 – 2020 ($Million) 4.6.2. Market Trend 4.6.3. Key Market Drivers 18.104.22.168. Large Patient Pool in the U.S. 22.214.171.124. Increasing Awareness 126.96.36.199. Government Regulations 4.6.4.
188.8.131.52. Ignoring the Existing Sleeping Disorder 4.6.5. Market Opportunities
About Us: Allied Market Research (AMR) is a full-service market research and business consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions”. AMR has a targeted view
to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
Contact: Sona Padman 5320 SW Macadam Avenue, Suite 100, Portland, OR 97239 United States Direct: +1 (617) 674-4143 Toll Free: +1 (855) 711-1555 (U.S. & Canada) Fax: +1 (855) 550-5975 Email: email@example.com Web: www.alliedmarketresearch.com â€˘
Published on Nov 21, 2013
The adoption and progress of technology is on a tremendous rise in the biological industry. Research and advancements are going on to replac...